You are here
- Home
- Therapy Areas
- Gastrointestinal
To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole
- Disease
- gastroesophageal reflux disease
- Drug Name
- Nexium
- Generic Name
- esomeprazole
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IV
- Start Date
- Jan 18, 1971
- Study Name
- D961HL00001
- Study Id
- D961HL00001
- ClinicalTrials.gov ID
- NCT01249651
- Recruiting Status
- Closed
- Report
-
Jun 6, 2012
- D961HL00001.pdf (218 KB)
